Rolf Kuropka

Statement: Rolf Kuropka, CEO, Krahn Chemie Group

CHEManager asked executives and industry experts from a broad range of chemical distributors to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.

News

Krahn Chemie takes over the business of Lapis

Topics • Chemistry

'People, Infrastructure and Processes that Differ Remarkably from Competitors'

Top-Feature

Evonik Industries AG

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

From Catalogue to Collaboration

Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Krahn Chemie